Brought to you by 
EMD Serono and Fast Forward team up for MS drug development
01 Apr 2009
Executive Summary
EMD Serono, the US operations of Merck KGAA's Merck Serono division, has teamed up with the National Multiple Sclerosis Society and its Fast Forward LLC subsidiary to research and develop new MS treatments.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
EMD Serono and Fast Forward team up for MS drug development
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice